Publications

Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness.

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.

Next-generation sequencing to assess HIV tropism.

CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.

Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.

A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.

Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score.